Cirrhosis of the liver and hepatocellular carcinoma in the outcome of chronic hepatitis C: a case report

Cirrhosis of the liver and hepatocellular carcinoma in the outcome of chronic hepatitis C: a case report

The article presents a clinical case of cirrhosis of the liver of class C according to Child – Pugh in the outcome of chronic hepatitis C and with the development of primary liver cancer. It is shown that early diagnosis of primary liver cancer and timely initiation of antiviral therapy with a direc...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Makashova, Kh. G. Omarova, Zh. B. Ponezheva, O. S. Astrina, V. V. Breder, I. V. Pogrebnyakov, I. A. Dzhanyan, S. A. Magomedova
Format:	Article
Language:	Russian
Published:	Open Systems Publication 2023-04-01
Series:	Лечащий Врач
Subjects:	a case from practice cirrhosis of the liver chronic hepatitis c antiviral therapy hepatocarcinoma covid-19
Online Access:	https://journal.lvrach.ru/jour/article/view/1033
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

The prevalence of viral hepatitis D in the world
by: V. G. Akimkin, et al.
Published: (2022-07-01)

EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

The Psychometric Hepatic Encephalopathy Score for Diagnosis of Minimal Hepatic Encephalopathy in Liver Cirrhosis Patient
by: Cokorde Istri Yuliandari Krisnawardani Kumbara, et al.
Published: (2024-05-01)

A clinical case of diagnosis of autoimmune hepatitis at the stage of liver cirrhosis
by: O. A. Svitlytska, et al.
Published: (2023-07-01)

FEATURES OF HEART LESIONS IN PATIENTS WITH VIRAL LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2018-07-01)

Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy
by: Yu Chen, et al.
Published: (2025-09-01)

Hepatitis C: una aproximación clínica y epidemiológica en Cali, Colombia
by: Carlos Arturo Rojas Rodríguez, et al.
Published: (2018-12-01)

Clinical and epidemiological characteristics of D hepatitis В and delta in the Republic of Dagestan
by: S. A. Magomedova, et al.
Published: (2023-10-01)

CLINICAL AND BIOCHEMICAL CHARACTERISTICS AT THE CIRRHOSIS OF VARIOUS GENESIS
by: A. R. Bilalova, et al.
Published: (2016-06-01)

ERADICATION OF HCV INFECTION IN PATIENTS WITH LIVER CIRRHOSIS: FACTOR OF CANCER PREVENTION OR CARCINOGENESIS?
by: N. A. Malinina, et al.
Published: (2019-06-01)

IMMUNOLOGICAL FEATURES IN LIVER CIRRHOSIS INDUCED BY HEPATITIS B VIRUS
by: O. I. Urazova, et al.
Published: (2014-07-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

The incidence of malignant tumors in patients with liver cirrhosis and the impact of the development of hepatocellular carcinoma on the overall survival of patients with cirrhosis
by: Vladislav V. Petkau, et al.
Published: (2024-03-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Prognostic factors in patients with hepatocellular cancer with progression after liver transplantation
by: I. A. Dzhanyan, et al.
Published: (2024-06-01)

Correlation between systemic inflammatory response syndrome and prognosis of patients with cirrhosis and hepatic encephalopathy
by: Kaiyue Zhang, et al.
Published: (2025-07-01)

Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia
by: Amgalan Byambasuren, et al.
Published: (2025-05-01)

MOLECULAR GENETIC ASPECTS OF HEPATOCELLULAR CARCINOMA PATHOGENESIS AND CURRENT OPTIONS OF DRUG THERAPY
by: A. S. Makarova
Published: (2017-12-01)

Minimal hepatic encephalopathy: a hidden threat to quality of life in cirrhosis patients
by: Mahtab Ghaemi
Published: (2025-07-01)

Study of Serum Zinc Level in Liver Cirrhosis and its Correlation with Stages of Hepatic Encephalopathy
by: Suraj Ramesh Hiwarkar, et al.
Published: (2023-04-01)

Morphological changes in the brain in liver cirrhosis of alcoholic and viral etiology
by: A. M. Maybogin, et al.
Published: (2022-12-01)

Principles of portal hypertension treatment at patients with liver cirrhosis
by: Ye. A. Fedosina, et al.
Published: (2012-09-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis
by: D. V. Garbuzenko
Published: (2012-04-01)

Transcatheter hepatic arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma before liver transplantation: the prognostic value of alpha-fetoprotein concentrations
by: D. A. Granov, et al.
Published: (2021-01-01)

The Higher Incidence of Liver Injury in HCC Patients Compared to Other Malignancies During Immune-Checkpoint Inhibitor Therapy is Primarily Due to Tumor Progression
by: Wang Y, et al.
Published: (2025-06-01)

Clinical and morphological variants of hepatitis onset with congenital cytomegalovirus and hepatitis C infection
by: R. A. Ushakova, et al.
Published: (2014-09-01)

Risk factors of development of hepatocellular carcinoma
by: V. T. Ivashkin, et al.
Published: (2009-02-01)

Taurochenodeoxycholic acid as a sensitive stratification marker for HBV-associated hepatic cirrhosis status has a hepatoprotective effect
by: Jingyan Zeng, et al.
Published: (2025-08-01)

Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial
by: Valeria Perez-Campuzano, et al.
Published: (2025-04-01)

Etiologic, epidemic, medical and economic aspects of hepatocellular carcinoma
by: N. A. Vlasova, et al.
Published: (2025-02-01)

Results of surgical treatment of patients, suffering hepatic cirrhosis and cholestatic syndrome
by: О. F. Dzygal, et al.
Published: (2018-07-01)

Quantitative assessment of hepatic function by indocyanine green clearance test
by: I. I. Dzidzava, et al.
Published: (2018-08-01)

Miniinvasive vascular interventions as an alternative surgical method for treatment of the patients, suffering hepatic cirrhosis and portal hypertension
by: О. F. Dzygal, et al.
Published: (2018-07-01)

INCIDENCE OF AUTOANTIBODIES IN PATIENTS WITH AUTOIMMUNE LIVER DISEASES AND CHRONIC HEPATITIS C
by: K. L. Raikhelson, et al.
Published: (2014-07-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

Kinetics of Virus Load HCV-RNA in Blood Serum and Peripheral Mononuclear Cells in a Patient with Hepatocirrhosis and Chronic Virus Hepatitis C Termination Treated According to Noninterferon Treatment Scheme (Cycloferon + Ribavirin)
by: V. C. Stelmah, et al.
Published: (2020-05-01)

Chemical pleurodesis using bleomycin in treatment of patients with transsudative pleural effusion in hepatic failure
by: A. L. Akopov, et al.
Published: (2017-06-01)